Sales rise 27.36% to Rs 417.84 crore
Net profit of ERIS Lifesciences rose 1.08% to Rs 101.86 crore in the quarter ended December 2022 as against Rs 100.77 crore during the previous quarter ended December 2021. Sales rose 27.36% to Rs 417.84 crore in the quarter ended December 2022 as against Rs 328.07 crore during the previous quarter ended December 2021.
ParticularsQuarter EndedDec. 2022Dec. 2021% Var.Sales417.84328.07 27 OPM %32.8437.10 –PBDT136.44125.86 8 PBT106.54108.98 -2 NP101.86100.77 1
Powered by Capital Market – Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Subscribe to Business Standard Premium
Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!
First Published: Wed, January 18 2023. 07:36 IST
PREVIOUS STORY
NEXT STORY
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU